Drug Shortage Report for MAR-METHIMAZOLE
Report ID | 176433 |
Drug Identification Number | 02480107 |
Brand name | MAR-METHIMAZOLE |
Common or Proper name | MAR-Methimazole |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | METHIMAZOLE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | H03BB |
ATC description | ANTITHYROID PREPARATIONS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2022-12-02 |
Estimated end date | 2023-02-15 |
Actual end date | 2022-01-05 |
Shortage status | Avoided shortage |
Updated date | 2023-01-05 |
Company comments | Shortage Resolved |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-12-01 | English | Compare |
v2 | 2022-12-01 | English | Compare |
v3 | 2022-12-01 | French | Compare |
v4 | 2022-12-02 | English | Compare |
v5 | 2022-12-02 | English | Compare |
v6 | 2022-12-02 | French | Compare |
v7 | 2022-12-02 | English | Compare |
v8 | 2022-12-02 | French | Compare |
v9 | 2022-12-03 | English | Compare |
v10 | 2023-01-05 | English | Compare |
v11 | 2023-01-05 | French | Compare |
Showing 1 to 11 of 11